Kaplan Matthew L.
- SEC CIK
- 0001895952
In the past year, 1 open-market purchase filing worth $64.2K and no sales.
Current role at each company
- NVCT Nuvectis Pharma, Inc.Directoras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $64.2K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$64.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kaplan Matthew L. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 (view filing) | Nov 5 | 1 day | Kaplan Matthew L.Director | PPurchase | +11.0K | $5.84 | +$64.2K | +9.7%124.8K after | |
| May 16, 2022 (view filing) | May 12 | 4 days | Kaplan Matthew L.Director | PPurchase | +3.00K | $16.88 | +$50.6K | +9.2%35.8K after | 2 lots |